PS Ratio Chart

View PS Ratio for INRLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
August 27, 2026 3.489
August 26, 2026 3.489
August 25, 2026 3.489
August 24, 2026 3.489
August 21, 2026 3.489
August 20, 2026 3.656
August 19, 2026 3.656
August 18, 2026 3.656
August 17, 2026 3.656
August 14, 2026 3.656
August 13, 2026 2.572
August 12, 2026 2.572
August 11, 2026 2.572
August 10, 2026 2.572
August 07, 2026 2.572
August 06, 2026 2.572
August 05, 2026 2.572
August 04, 2026 2.572
August 03, 2026 2.572
July 31, 2026 2.572
July 30, 2026 2.572
July 29, 2026 2.778
July 28, 2026 2.778
July 27, 2026 2.778
July 24, 2026 2.778
Date Value
July 23, 2026 2.778
July 22, 2026 2.778
July 21, 2026 2.778
July 20, 2026 2.778
July 17, 2026 2.778
July 16, 2026 2.778
July 15, 2026 2.778
July 14, 2026 2.778
July 13, 2026 2.778
July 10, 2026 2.778
July 09, 2026 2.778
July 08, 2026 2.778
July 07, 2026 2.778
July 06, 2026 2.778
July 02, 2026 2.778
July 01, 2026 2.778
June 30, 2026 2.778
June 29, 2026 2.462
June 26, 2026 2.462
June 25, 2026 2.462
June 24, 2026 2.351
June 23, 2026 2.351
June 22, 2026 2.424
June 18, 2026 2.424
June 17, 2026 2.424

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Nicox SA 1.24
DBV Technologies SA --
Cellectis SA 6.128
Genfit SA 10.63
Innate Pharma SA 64.42

PS Ratio Related Metrics

PEG Ratio -0.0233
Price to Book Value 6.728
Price 3.29
Earnings Yield -31.82%
Market Cap 623.94M
PEGY Ratio -0.0233